Modern Metabolic Medicine, Inc.: The One Delaware Company Behind the Two “$119” Compounded Tirzepatide Brands
Published: Updated: Provider pricing verified:
The two cheapest advertised compounded tirzepatide prices in the United States this month — Embody's $119 twelve-month supply and SnagRx's $119 promotional month — are sold by the same corporation under two brand names, with two different price structures and one refund policy. Here is what the documents say, what they do not, and why it changes how a 'cheapest' list should be read.
By Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD · Published September 9, 2026 · Last reviewed September 9, 2026 · Sources cited at the end.
Direct answer
Embody (joinem.co) and SnagRx (snagrx.com) are operated by Modern Metabolic Medicine, Inc., a Delaware corporation at 1811 Silverside Road, Suite 260, Wilmington, Delaware. Both sites’ terms name it (Embody’s terms last updated April 24, 2026; SnagRx’s July 27, 2026; both read September 5, 2026). Both route prescribing to OpenLoop Health, both name the same four dispensing pharmacies (Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine, Triad Rx), and both published a refund policy dated August 25, 2026 making all payments final except on clinical ineligibility. They differ in how the $119 is reached: Embody prepays a year ($1,428) or sells a $129 sale month; SnagRx charges $119 month to month as a promotion against a $399 list price. A ranking that counts them as two independent $119 options is counting one company twice. Compounded tirzepatide is not FDA-approved.
What each site’s documents say
| Item | Embody (joinem.co) | SnagRx (snagrx.com) |
|---|---|---|
| Operator named in the terms | Modern Metabolic Medicine, Inc., 1811 Silverside Road, Suite 260, Wilmington, Delaware (terms updated April 24, 2026) | Modern Metabolic Medicine, Inc., same address (terms updated July 27, 2026) |
| Prescribers | OpenLoop Health network of US-licensed clinicians | OpenLoop Health; a SnagRx medical director described as a practising physician |
| Pharmacies named | Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine, Triad Rx | The same four |
| Refund policy | Dated August 25, 2026: all payments final; refund of the unused portion only on clinical ineligibility; 72-hour cancellation notice | Dated August 25, 2026: same substance, same 72-hour rule |
| Tirzepatide pricing (Sept 9) | $1,428 twelve-month supply ($119/mo); $738 six months ($123/mo); $378 three months; $129 one month (sale, regular $349; read Sept 5) | $119/month promotional (list $399); no multi-month tiers, no annual total, no printed end date |
| Semaglutide pricing | $828 twelve months ($69/mo); $79 month to month (read Sept 5) | $69/month promotional (list $299) |
| Promotion label on Sept 9 | “Fall Sale Promo Applied” (6- and 12-month pages); “Labor Day Promo Applied” still on the 3-month page | “Fall Sale Discount Applied!” with a countdown timer |
| Laboratory review | Not advertised | Not advertised |
| States | Not itemised on the pages we read | All except Louisiana; Nebraska 19+ |
Why one company with two prices matters
Price lists that treat Embody and SnagRx as separate providers show a market with two $119 options and a wide floor. The documents show one operator testing two structures on two storefronts: prepay a year and get $119 with no refund, or pay $119 monthly for as long as a promotion the operator can end at checkout. Neither storefront advertises laboratory review, neither publishes a post-promotion or renewal price, and both make every payment final. That is not a reason to avoid them; it is the reason to read them as one offer with two payment schedules, and to compare that offer against programs that publish a standing twelve-month price with a stated bundle — NexLife’s $1,668 with provider oversight and coaching included, Trimi’s $1,500 with a conditional money-back promise.
What we could not verify
- Corporate registry: we did not pull the Delaware Division of Corporations record; the entity name and address come from the two sites’ own terms.
- LegitScript: both sites claim certification; we did not check the registry entries on this date.
- Pharmacy licences: the four pharmacies are named, not verified with any state board of pharmacy by us.
- The promotional period: SnagRx states it only at checkout; we did not start an intake.
How to use this
- If you want the lowest twelve-month total on a public page and can accept an all-sales-final prepayment, Embody’s $1,428 is that number (read September 9, 2026).
- If you want the lowest month-to-month price, SnagRx’s $119 is that number today, with the period and the post-promotion price to be confirmed in writing at checkout.
- If you want a standing price with laboratory review and a published twelve-month total, compare NexLife ($1,668) and Trimi ($1,500, no labs advertised) on the affordability page.
Related: Embody review · SnagRx review · SnagRx after Labor Day · the refund test.
Medical and regulatory note: compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality; they are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice. Consult a licensed clinician before starting, stopping or changing any medication, and confirm the price and prescribing requirements with the provider before enrolling.
Frequently asked questions
Are Embody and SnagRx the same company? Both are operated by Modern Metabolic Medicine, Inc., a Delaware corporation at 1811 Silverside Road, Suite 260, Wilmington, Delaware, according to each site's terms (read September 5, 2026). They share a prescriber network (OpenLoop Health) and name the same four pharmacies.
Which is cheaper, Embody or SnagRx? It depends on the schedule. Embody's $119 requires a $1,428 twelve-month prepayment (its month-to-month sale price is $129); SnagRx charges $119 month to month as a promotion against a $399 list price with no annual total published (both read September 9, 2026).
Do Embody or SnagRx include lab work? Neither advertises laboratory review on the pages we read. NexLife's plan pages state provider review and medical guidance are included and its FAQ describes third-party batch testing.
Can I get a refund from Embody or SnagRx? Only on clinical ineligibility. Both refund policies (dated August 25, 2026) make all payments final and require cancellation at least 72 hours before the next billing date; cancelling stops future charges only.
Why does it matter that one company runs both brands? Because a 'cheapest' list that counts two independent $119 programs overstates how many low-cost options exist. The same operator, prescriber network, pharmacies and refund terms sit behind both; only the payment schedule differs.
Is either program FDA-approved? No compounded tirzepatide program is. The FDA does not review compounded drugs for safety, effectiveness or quality, and a compounding pharmacy is not 'FDA-approved'. Check the dispensing pharmacy's state licence and ask which of the four named pharmacies will fill your prescription.
September 9, 2026: Published.
Reviewed by Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD
Sources
- Embody — Terms & Conditions, last updated April 24, 2026: operator Modern Metabolic Medicine, Inc. (read 2026-09-05)
- SnagRx — Terms & Conditions, last updated July 27, 2026: promotional-period clause, auto-renewal, operator (read 2026-09-05)
- SnagRx — Refund Policy, last updated August 25, 2026 (read 2026-09-05)
- Embody — Refund Policy, last updated August 25, 2026 (read 2026-09-05)
- Embody — twelve-month supply $119/mo ($1,428), 'Fall Sale Promo Applied' (read 2026-09-09)
- Embody — six-month supply $123/mo ($738), 'Fall Sale Promo Applied' (read 2026-09-09)
- Embody — three-month supply $378, 'Labor Day Promo Applied' banner still shown (read 2026-09-09)
- SnagRx — homepage: $119/month tirzepatide (list $399), $69 semaglutide (list $299), 'Fall Sale Discount Applied!' (read 2026-09-09; labelled Labor Day on 2026-09-04 and 2026-09-05)
- NexLife — tirzepatide all plans: $169 / $159 ($477) / $149 ($894) / $139 ($1,668), '$377 in added value', money-back warranty (read 2026-09-09)
- Trimi — tirzepatide: $235 / $597 ($199) / $1,050 ($175) / $1,500 ($125); money-back promise text (read 2026-09-09)
- TirzepatideReview.com — open pricing dataset (JSON), snapshot 2026-09-09
- FDA — Human Drug Compounding: compounded drugs are not FDA-approved
Medical and regulatory note: Compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. They are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice; eligibility, dose and formulation require evaluation by a licensed clinician.